Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mylan NV Ord Shs (MYL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
TB Alliance and Mylan Announce Global Collaboration to Commercialize Investigational Drug Pretomanid as Part of Two Regimens to Treat Tuberculosis (TB)

Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan N.V. (NASDAQ: MYL), today announced a global collaboration to make the experimental drug pretomanid accessible for use in two investigational...

MYL : 26.72 (-0.48%)
Allergan Falls as Supreme Court Dismisses Restasis Litigation

Allergan's (AGN) key drug, Restasis' prospects hurt as the U.S. Supreme Court upholds the ruling of a lower court, which invalidated certain patents protecting the drug.

MYL : 26.72 (-0.48%)
AGN : 140.26 (-0.04%)
NVS : 75.40 (-1.32%)
TEVA : 14.70 (+2.37%)
Watch for Mylan Nv to Potentially Rebound After Falling 1.04% Yesterday

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $26.69 to a high of $26.81. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $26.80 on...

MYL : 26.72 (-0.48%)
Acorda to Gain From Inbrija Sales and Neurological Pipeline

Acorda (ACOR) aims to boost sales with the launch of its newly FDA-approved Parkinson's disease drug, Inbrija. The company's pipeline looks promising as well.

MYL : 26.72 (-0.48%)
PDLI : 3.49 (-2.51%)
ACOR : 10.92 (-1.97%)
KMDA : 6.23 (+0.97%)
Mylan Nv (MYL) Breaks Through Resistance at $27.20

Shares of Mylan Nv (NASDAQ:MYL) have bullishly opened above the pivot of $26.91 today and have reached the first resistance level of $27.20. Should the shares continue to rise, the resistance pivots of...

MYL : 26.72 (-0.48%)
Striving to Create Better Health for a Better World: Mylan's Global Social Responsibility 2018 Progress Report Now Available

Global pharmaceutical company Mylan N.V. (NASDAQ:MYL) is committed to doing its part to achieve a positive, sustained impact on the world around us, from ensuring responsible operations that provide high...

MYL : 26.72 (-0.48%)
Mylan Nv Set to Possibly Rebound After Yesterday's Selloff of 1.97%

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $27.91 to a high of $28.18. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $27.95 on...

MYL : 26.72 (-0.48%)
After Yesterday's Decline of 1.97%, Mylan Nv Offers Investors Better Value

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $27.91 to a high of $28.18. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $27.95 on...

MYL : 26.72 (-0.48%)
Mylan (MYL) Up 8.6% Since Last Earnings Report: Can It Continue?

Mylan (MYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MYL : 26.72 (-0.48%)
Falling Earnings Estimates Signal Weakness Ahead for Mylan (MYL)

Mylan (MYL) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

MYL : 26.72 (-0.48%)
RDY : 40.50 (-0.66%)
Look for Shares of Mylan Nv to Potentially Rebound after Yesterday's 1.25% Sell Off

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $28.17 to a high of $28.46. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $28.32 on...

MYL : 26.72 (-0.48%)
Mylan Nv Falls 1.25% on Heavy Volume: Watch For Potential Rebound

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $28.17 to a high of $28.46. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $28.32 on...

MYL : 26.72 (-0.48%)
Glaxo Presents Encouraging Data on Endometrial Cancer Drug

Glaxo (GSK) presents encouraging data from phase I/II study on endometrial cancer drug, dostarlimab.

MYL : 26.72 (-0.48%)
MRK : 73.46 (+0.37%)
GSK : 39.68 (-0.43%)
PFE : 38.98 (-1.02%)
After Yesterday's Rally of 1.63% Shares Could Potentially Pullback

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $27.93 to a high of $28.74. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $28.55...

MYL : 26.72 (-0.48%)
Watch for Mylan Nv to Potentially Pullback After Gaining 1.63% Yesterday

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $27.93 to a high of $28.74. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $28.55...

MYL : 26.72 (-0.48%)
Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate Matter

Mylan Institutional LLC is conducting a voluntary nationwide recall of two lots (see table below) of Levoleucovorin Injection, 250 mg/25 mL tothe consumer/user level. The lots were manufactured by Alidac...

MYL : 26.72 (-0.48%)
Mapi Pharma Receives Government of Israel Funding for the Establishment of a Finished Dosage Form Facility for the Manufacturing of GA Depot Pharmaceuticals

Mapi Pharma Ltd., a fully integrated, clinical, late stage biopharmaceutical company, announced today that it has received complementary funding from the Israeli Ministry of the Economy to build a new...

MYL : 26.72 (-0.48%)
MAPI : N/A (unch)
Mylan Nv is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (MYL , OMER , PCRX , HZNP , LCI )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

MYL : 26.72 (-0.48%)
PCRX : 38.75 (+5.27%)
OMER : 18.68 (+0.86%)
Insys Plunges on Auditor's Concern About Insufficient Funds

Insys Therapeutics' (INSY) shares plunge after its auditor raises concerns related to insufficiency of funds to continue operations.

MYL : 26.72 (-0.48%)
ENDP : 7.15 (+0.42%)
INSY : 4.32 (+2.61%)
TEVA : 14.70 (+2.37%)
Mylan Nv Set to Possibly Pullback After Yesterday's Rally of 1.33%

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $27.35 to a high of $27.59. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $27.32...

MYL : 26.72 (-0.48%)

Van Meerten Stock Picks

AppFolio - Pick of the Day
My Stock Pick of the Day belongs to the software company AppFolio (APPF).
APPF +4.10
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar